drugset / Trial / NCT02592863

Trental for the Treatment of Vertigo/Dizziness/Imbalance

NCT02592863

Terminated 26 enrolled University of Missouri-Columbia
RandomizedParallel-groupDouble-blindTreatment

Summary

Imbalance, dizziness and vertigo as a result of problems in the inner ear (vestibular dysfunction) are becoming increasingly more prevalent in Americans 40 years of age and older. The symptoms have a severe impact on affected individuals with detrimental effects on work, travel, social and family life. These patients see doctors often with no relief in their symptoms. The most promising help for these patients is to use medication that will increase blood flow to the inner ear. Pentoxifylline (Trental) has been shown to increase microvascular blood flow.

Timeline

Start
2015-01
Primary completion
2020-12-31
Completion
2021-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule

Indications